|
Volumn 91, Issue 4, 2001, Pages 516-522
|
Locoregional treatment of low-grade B-cell lymphoma with CD3×CD19 bispecific antibodies and CD28 costimulation: II. Assessment of cellular immune responses
|
Author keywords
B cell lymphoma; Bispecific antibody; ELISpot; Immunotherapy; Lymphoma specific immune response
|
Indexed keywords
BISPECIFIC ANTIBODY;
CD19 ANTIBODY;
CD28 ANTIBODY;
CD3 ANTIBODY;
GAMMA INTERFERON;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ANTIBODY RESPONSE;
APOPTOSIS;
ARTICLE;
B CELL LYMPHOMA;
CANCER GRADING;
CANCER IMMUNOTHERAPY;
CELL ACTIVATION;
CELL INFILTRATION;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
HUMAN;
HUMAN TISSUE;
IMMUNE SYSTEM;
LYMPH NODE;
MALE;
NATURAL KILLER CELL;
PRIORITY JOURNAL;
RECEPTOR UPREGULATION;
SIGNAL TRANSDUCTION;
STIMULATION;
T LYMPHOCYTE;
AGED;
AGED, 80 AND OVER;
ANIMALS;
ANTIBODIES, BISPECIFIC;
ANTIGENS, CD19;
ANTIGENS, CD28;
ANTIGENS, CD3;
APOPTOSIS;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
CYTOKINES;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FLOW CYTOMETRY;
HLA-DR ANTIGENS;
HUMANS;
IMMUNOGLOBULINS;
IMMUNOTHERAPY;
IN SITU NICK-END LABELING;
KILLER CELLS, NATURAL;
LEUKEMIA, B-CELL;
LYMPH NODES;
LYMPHOCYTE ACTIVATION;
LYMPHOMA, B-CELL;
LYMPHOMA, FOLLICULAR;
LYMPHOMA, MANTLE-CELL;
MALE;
MICE;
MIDDLE AGED;
MODELS, BIOLOGICAL;
PHENOTYPE;
T-LYMPHOCYTES;
TIME FACTORS;
TOMOGRAPHY, X-RAY COMPUTED;
UP-REGULATION;
|
EID: 0035865962
PISSN: 00207136
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1069>3.0.CO;2-A Document Type: Article |
Times cited : (18)
|
References (20)
|